The biggest middleman in the prescription drug supply chain now makes drugs

May 14, 2024
With pharmaceutical mergers more common, the FTC is taking a hard look at pharmacy benefit managers and antitrust concerns.
In 2023, CVS founded Cordavis, a wholly owned subsidiary of CVS Health, to manufacture biosimilar prescription drugs.
Brendan Smialowski/AFP via Getty Images